Natco Pharma Enters USD 3.2 Billion US Pomalidomide Market, Claims 180-Day Exclusivity
Hyderabad: NATCO Pharma Limited, in partnership with Breckenridge Pharmaceutical, Inc., has announced the launch of Pomalidomide Capsules in the United States, a generic version of Pomalyst marketed by Celgene.Pomalidomide, a…